Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer ‘Two drugs in one’ candidate, developed in China, is a highlight at ASCO

https://www.statnews.com/2026/05/31/squamous-cell-lung-cancer-akeso-summit-harmoni-asco-2026/ By Matthew HerperMay 31, 2026 Senior Writer, Medicine, Editorial Director of Events